The Civil Aviation Authority of the Philippines (CAAP) has extended its flight ban over Mayon Volcano in Albay anew until ...

MANILA, Philippines — The issued Notice to Airmen (NOTAM) covering flights near Mayon Volcano in Albay has been extended ...

The Hayli Gubbi volcano in the rural northeast of Ethiopia erupted November 23. Afar Communication Bureau via Facebook A volcano in northern Ethiopia erupted Sunday, marking its first known eruption ...

A long-dormant volcano erupted in northern Ethiopia over the weekend, sending ash plumes across the Red Sea toward Yemen and Oman. The Hayli Gubbi volcano in the Afar region of Ethiopia erupted on ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Abbott announced Thursday morning that it is acquiring Exact Sciences for $21 billion. The deal values Exact Sciences at $105 per share, representing a 22% premium to the cancer screening company’s ...